Kevin Song
About
Kevin Song is a scholar working on Hematology, Oncology and Molecular Biology.
According to data from OpenAlex, Kevin Song has authored 181 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Hematology, 92 papers in Oncology and 69 papers in Molecular Biology. Recurrent topics in Kevin Song's work include Multiple Myeloma Research and Treatments (90 papers), Protein Degradation and Inhibitors (47 papers) and Cancer Treatment and Pharmacology (38 papers). Kevin Song is often cited by papers focused on Multiple Myeloma Research and Treatments (90 papers), Protein Degradation and Inhibitors (47 papers) and Cancer Treatment and Pharmacology (38 papers). Kevin Song collaborates with scholars based in Canada, United States and France. Kevin Song's co-authors include Donna E. Hogge, Donna L. Forrest, Cynthia L. Toze, John D. Shepherd, Thomas J. Nevill, Nelson Leung, Michael J. Barnett, Heather J. Sutherland, Joseph M. Connors and Stephen H. Nantel and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Kevin Song
162 papers receiving 2.6k citations
Peers
Kevin Song
Sung‐Eun Lee South Korea
Mohamed E. Salama United States
Lucía López‐Corral Spain
Francesca Bonifazi Italy
Meral Beksaç Türkiye
Luciano J. Costa United States
Johannes Schetelig Germany
Christoph Röllig Germany
Yue Cui China
Hans Michael Kvasnicka Germany
Citations per year, relative to Kevin Song Kevin Song (= 1×)
peers
Sung‐Eun Lee
Countries citing papers authored by Kevin Song
Since
Specialization
Citations
This map shows the geographic impact of Kevin Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Song more than expected).
Fields of papers citing papers by Kevin Song
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kevin Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Song. The network helps show where Kevin Song may publish in the future.
Co-authorship network of co-authors of Kevin Song
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Song. A scholar is included among the top collaborators of Kevin Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Song. Kevin Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ramírez-GarcíaLuna, José L., et al.. (2025). Transversus abdominis plane block for postoperative pain management and opioid sparing: a systematic review and meta-analysis of randomised controlled trials. British Journal of Anaesthesia. 136(1). 266–282.
2.
Venner, Christopher P., Peter Duggan, Kevin Song, et al.. (2024). Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database. Transplantation and Cellular Therapy. 30(9). 889–901.
3.
Bahlis, Nizar J., Christy Samaras, Donna Reece, et al.. (2024). Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014. Clinical Lymphoma Myeloma & Leukemia. 24(12). 852–862.
4.
Lancman, Guido, Kevin Song, Darrell White, et al.. (2024). Recommendations for the effective use of T-cell–redirecting therapies: a Canadian consensus statement. Frontiers in Oncology. 14. 1446995–1446995.
5.
Bahlis, Nizar J., Christy Samaras, Donna Reece, et al.. (2023). MM-371 Pomalidomide, Daratumumab, and Dexamethasone After Lenalidomide Treatment in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): Final Overall Survival (OS) Analysis of the Phase II MM-014 Study. Clinical Lymphoma Myeloma & Leukemia. 23. S494–S495.
6.
McCurdy, Arleigh, Donna Reece, Christopher P. Venner, et al.. (2023). Second Line Treatment and Outcomes of Patients with Multiple Myeloma: A Real World Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database. Blood. 142(Supplement 1). 3364–3364.
7.
Bahlis, Nizar J., Christy Samaras, Donna Reece, et al.. (2023). P882: POMALIDOMIDE, DARATUMUMAB, AND DEXAMETHASONE AFTER LENALIDOMIDE TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): FINAL OVERALL SURVIVAL ANALYSIS OF THE PHASE 2 MM-014 STUDY. HemaSphere. 7(S3). e757660c–e757660c.
8.
Villa, Diego, Ciara L. Freeman, Graham W. Slack, et al.. (2022). Clinicopathological characteristics and long‐term outcomes of plasmablastic lymphoma in British Columbia. British Journal of Haematology. 199(2). 230–238.
9.
Lu, Weipeng, Shuang Wu, Jun-Hui Ou, et al.. (2022). Intelligent System for Distributed Deep Learning Training Traffic Optimization. 1358–1365.
10.
Mourad, Yasser Abou, Donna L. Forrest, Alina S. Gerrie, et al.. (2021). Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population. Clinical Lymphoma Myeloma & Leukemia. 21(7). 476–482.
11.
Callander, Natalie S., Vincent Ribrag, Paul G. Richardson, et al.. (2021). DREAMM-5 Study: Investigating the Synergetic Effects of Belantamab Mafodotin Plus Inducible T-Cell Co-Stimulator Agonist (aICOS) Combination Therapy in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 138(Supplement 1). 897–897.
12.
Topp, Max S., Tom van Meerten, Roch Houot, et al.. (2019). Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Large B Cell Lymphoma. Blood. 134(Supplement_1). 243–243.
13.
Tsang, Erica S., Diego Villa, Federica Loscocco, et al.. (2017). Comparative Effectiveness of High-Dose Bendamustine-EAM Versus BEAM in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation. Blood. 130. 3291–3291.
14.
Siegel, David, Gary J. Schiller, Kevin Song, et al.. (2017). Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) Safety and Efficacy in Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM) Previously Treated with a Proteasome Inhibitor (PI) and in Whom Last Prior Therapy with Lenalidomide (LEN) Failed. Blood. 130. 1812–1812.
15.
Lad, Deepesh, Yasser Abou Mourad, Michael J. Barnett, et al.. (2016). Pre-Transplant Vitamin D Deficiency is Associated with Inferior Overall Survival but not Associated with Relapse Free Survival or Cumulative Incidence of GVHD Post Adult Hematopoietic Cell Transplantation for Hematological Malignancies. Biology of Blood and Marrow Transplantation. 22(3). S334–S334.
16.
Corso, Alessandro, Michel Delforge, Kevin Song, et al.. (2015). HEALTH RESOURCE UTILIZATION WITH CONTINUOUS LENALIDOMIDE TREATMENT (TX) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM). Haematologica. 100. 24–25.
17.
Connors, Joseph M., Laurie H. Sehn, Diego Villa, et al.. (2013). Gemcitabine, Dexamethasone, and Cisplatin (GDP) As Secondary Chemotherapy In Relapsed/Refractory Peripheral T-Cell Lymphoma. Blood. 122(21). 4345–4345.
18.
Savoie, Mary Lynn, Kevin Song, Donna L. Forrest, et al.. (2006). Shifting to outpatient management of acute myeloid leukemia: a prospective experience. Annals of Oncology. 17(5). 763–768.
19.
Forrest, Donna L., Donna E. Hogge, Thomas J. Nevill, et al.. (2005). High-Dose Therapy and Autologous Hematopoietic Stem-Cell Transplantation Does Not Increase the Risk of Second Neoplasms for Patients With Hodgkin's Lymphoma: A Comparison of Conventional Therapy Alone Versus Conventional Therapy Followed by Autologous Hematopoietic Stem-Cell Transplantation. Journal of Clinical Oncology. 23(31). 7994–8002.
20.
Song, Kevin, Peter Mollee, Armand Keating, & Michael Crump. (2003). Autologous stem cell transplant for relapsed and refractory peripheral T‐cell lymphoma: variable outcome according to pathological subtype. British Journal of Haematology. 120(6). 978–985.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sung‐Eun Lee Breakdown of academic impact, for papers by Mohamed E. Salama Breakdown of academic impact, for papers by Lucía López‐Corral Breakdown of academic impact, for papers by Francesca Bonifazi Breakdown of academic impact, for papers by Meral Beksaç Breakdown of academic impact, for papers by Luciano J. Costa Breakdown of academic impact, for papers by Johannes Schetelig Breakdown of academic impact, for papers by Christoph Röllig Breakdown of academic impact, for papers by Yue Cui Breakdown of academic impact, for papers by Hans Michael Kvasnicka